Alexander J. Boddy

Alexander J. Boddy

Auto-generated profile, based on publicly available information

Alexander J. Boddy

Medicinal Chemistry, Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in Organic Chemistry Frontiers
Verified
Journal Article
Open access
PDF file
ABAlexander J. Boddy
Alexander J. Boddy
JBJames A Bull
James A Bull
This review summaries recent synthetic developments towards spirocyclic oxindoles and applications as valuable medicinal and synthetic targets.

5 December 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
ABAlexander J. Boddy
Alexander J. Boddy
DADominic P. Affron
Dominic P. Affron
CCChristopher J. Cordier
Christopher J. Cordier
EREmma L. Rivers
Emma L. Rivers
ASAlan Spivey
Alan Spivey
JBJames A Bull
James A Bull
Methods that provide rapid access to new heterocyclic structures in biologically relevant chemical space provide important opportunities in drug discovery. Here, a strategy is described for the preparation of 2,2‐disubstituted azetidines, pyrrolidines, piperidines, and azepanes bearing ester and diverse aryl substituents. A one‐pot rhodium catalyzed N–H insertion and cyclization sequence uses diazo compounds to stitch together linear 1,m‐haloamines (m=2–5) to rapidly assemble 4 ‐, 5 ‐, 6 ‐, and 7 ‐membered saturated nitrogen heterocycles in excellent yields. Over fifty examples are demonstrated, including examples with diazo compounds derived from biologically active compounds. The products can be functionalized to afford α,α‐disubstituted amino acids and applied to fragment synthesis.

13 May 2019 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
RCRosemary A. Croft
Rosemary A. Croft
MDMaryne A. J. Dubois
Maryne A. J. Dubois
ABAlexander J. Boddy
Alexander J. Boddy
CDCamille Denis
Camille Denis
ALAnna Lazaridou
Anna Lazaridou
JBJames A Bull
James A Bull

4 March 2019 in Organic Letters
Verified
Journal Article
Closed access
ABAlexander J. Boddy
Alexander J. Boddy
CCChristopher J. Cordier
Christopher J. Cordier
KGKristin Goldberg
Kristin Goldberg
AMAndrew Madin
Andrew Madin
ASAlan Spivey
Alan Spivey
JBJames A Bull
James A Bull

5 December 2018 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
ABAlexander J. Boddy
Alexander J. Boddy
DADominic P. Affron
Dominic P. Affron
CCChristopher J. Cordier
Christopher J. Cordier
EREmma L. Rivers
Emma L. Rivers
ASAlan Spivey
Alan Spivey
JBJames A Bull
James A Bull
Methods that provide rapid access to new heterocyclic structures in biologically relevant chemical space provide important opportunities in drug discovery. Here, a strategy is described for the preparation of 2,2‐disubstituted azetidines, pyrrolidines, piperidines, and azepanes bearing ester and diverse aryl substituents. A one‐pot rhodium catalyzed N–H insertion and cyclization sequence uses diazo compounds to stitch together linear 1,m‐haloamines (m=2–5) to rapidly assemble 4 ‐, 5 ‐, 6 ‐, and 7 ‐membered saturated nitrogen heterocycles in excellent yields. Over fifty examples are demonstrated, including examples with diazo compounds derived from biologically active compounds. The products can be functionalized to afford α,α‐disubstituted amino acids and applied to fragment synthesis.

15 October 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DNDavid F. Nippa
David F. Nippa
ABAlexander J. Boddy
Alexander J. Boddy
KAKenneth Atz
Kenneth Atz
Uwe GretherUwe Grether
Uwe Grether
HBHayley Binch
Hayley Binch
RMRainer E. Martin
Rainer E. Martin
This opinion addresses how digitalisation and automation can reduce the synthesis bottleneck in the DMTA cycle. Current automated synthesis & planning, future data-rich integrated platforms, and the medicinal chemist's evolving role are reviewed.